about
[Haemostasis dysregulation in filovirus infections].Human transmission of Ebola virus.VP40 octamers are essential for Ebola virus replication.Ebola virus failure to stimulate plasmacytoid dendritic cell interferon responses correlates with impaired cellular entry.Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection.In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity.Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs.Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody.Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication.Role of Ebola virus VP30 in transcription reinitiation.Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins.Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.Characterization of a Novel Neutralizing Monoclonal Antibody Against Ebola Virus GP.RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor.Entry of Ebola Virus is an Asynchronous Process.Role of VP30 phosphorylation in the Ebola virus replication cycle.VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.Modeling Ebolavirus Budding with Virus Like Particles.Characterization of the Unconventional Secretion of the Ebola Matrix Protein VP40.[A first outbreak of Ebola virus in West Africa].Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1.Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level.Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.Conserved proline-rich region of Ebola virus matrix protein VP40 is essential for plasma membrane targeting and virus-like particle release.Filovirus proteins for antiviral drug discovery: Structure/function of proteins involved in assembly and budding.Mannoside Glycolipid Conjugates Display Antiviral Activity Against Ebola VirusInvolvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction
P50
Q27691452-0F4AEF0F-7D51-4E3A-B314-76A6C02BFE8FQ30239948-5908B474-68B9-41CA-84B6-86D4218BD2D1Q33718451-44454D4A-6888-4B5E-B32B-F4F146F5B990Q35299974-8A1105FF-9B11-42F7-B4C4-D12487BCA5EEQ35300048-6F5A8736-673E-40E6-861A-612E5A46CC4AQ35694262-DE525279-6C3B-49B3-8216-AF537AC86BC2Q36046633-65A6DD73-54C0-49CC-B071-55C3EC001857Q36376567-A6F5CED2-CED9-41D4-96A3-BF17D48E6E5FQ36403417-D89F6FDB-E9C2-441F-BDBE-B75D6B4ABE0BQ36994598-1656CCF2-C6A8-4EE0-984C-8E161C077C82Q37333887-B8A72796-8C28-4373-B144-7BABFD1524B8Q38785688-4806E5BE-AED8-4467-9AFE-98C32339413EQ38847348-AC966B22-9F03-4454-BAE7-CF6A1F8CA36FQ38857149-F0A47631-F3E9-4FE5-B61A-D133F59856F5Q38879034-D63DBDB2-EC32-450A-9F2A-A403EE675E5FQ39457092-A7FE0558-C4D7-4B71-9E29-6A9396D23ECBQ39457108-ACC81922-12A0-4840-BD8E-DC742D0C2DD7Q40054512-1EFD3614-1D4D-4B82-A2C9-FD95951FC5D9Q40087506-26A02149-CA28-424D-AF94-AEA0E83B7615Q40200620-8F04975D-D7CB-45A0-8A63-2B6911629B9BQ40214327-BBCF8079-FA42-4D3D-8306-BA6C5D227012Q40294344-3500B167-6310-4D19-A559-0BC8BBD99C44Q40309113-719E13D6-AFD0-4A9B-AAB3-63A82CEED2B6Q40309158-48CC2625-72B3-47DE-B055-FC88FBE51AE7Q47203833-76F94522-0F95-4DCB-A9B9-D997FCA6D7B2Q57091911-67569158-D9A7-46FB-9C13-5EBB84D0B129Q61813268-9DADD928-C448-4497-8EF7-69C5EB4E9077
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Olivier Reynard
@ast
Olivier Reynard
@en
Olivier Reynard
@es
Olivier Reynard
@nl
type
label
Olivier Reynard
@ast
Olivier Reynard
@en
Olivier Reynard
@es
Olivier Reynard
@nl
prefLabel
Olivier Reynard
@ast
Olivier Reynard
@en
Olivier Reynard
@es
Olivier Reynard
@nl
P106
P31
P496
0000-0001-7536-355X